SAN DIEGO (BUSINESS WIRE) Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today participation in the following upcoming investor conferences:Morgan Stanley 21st Annual Global Healthcare Conference, September 11-13, 2023, NY, NY:Pipeline management.
/PRNewswire/ Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying.